Dupilumab (Dupixent) for skin infection in eczema

IRB
CHLA-18-00086
Effect of Dupilumab (anti-IL4Rα) on the Host-Microbe Interface in Atopic Dermatitis - ATOPIC DERMATITIS RESEARCH NETWORK PROTOCOL-ADRN 09

To find out the effects of dupilumab (Dupixent) on skin infection in eczema.

Study Details
Clinical Trials Government Identifier
NCT03389893
Keywords
dupilumab atopic dermatitis, skin, dupixent
Eligibility
Adults 18 to 65 years with moderate to severe eczema (atopic dermatitis)
Does this study also recruit healthy volunteers?
No
Enrollment Status
Closed
Coordinator Contact
Sydney Brown
Contact Email
sybrown@chla.usc.edu
Contact Email
pyong@chla.usc.edu